Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke : 1-year outcomes of the SELECT2 trial
Copyright © 2024 Elsevier Ltd. All rights reserved..
BACKGROUND: Multiple randomised trials have shown efficacy and safety of endovascular thrombectomy in patients with large ischaemic stroke. The aim of this study was to evaluate long-term (ie, at 1 year) evidence of benefit of thrombectomy for these patients.
METHODS: SELECT2 was a phase 3, open-label, international, randomised controlled trial with blinded endpoint assessment, conducted at 31 hospitals in the USA, Canada, Spain, Switzerland, Australia, and New Zealand. Patients aged 18-85 years with ischaemic stroke due to proximal occlusion of the internal carotid artery or of the first segment of the middle cerebral artery, showing large ischaemic core on non-contrast CT (Alberta Stroke Program Early Computed Tomographic Score of 3-5 [range 0-10, with lower values indicating larger infarctions]) or measuring 50 mL or more on CT perfusion and MRI, were randomly assigned, within 24 h of ischaemic stroke onset, to thrombectomy plus medical care or to medical care alone. The primary outcome for this analysis was the ordinal modified Rankin Scale (range 0-6, with higher scores indicating greater disability) at 1-year follow-up in an intention-to-treat population. The trial is registered at ClinicalTrials.gov (NCT03876457) and is completed.
FINDINGS: The trial was terminated early for efficacy at the 90-day follow-up after 352 patients had been randomly assigned (178 to thrombectomy and 174 to medical care only) between Oct 11, 2019, and Sept 9, 2022. Thrombectomy significantly improved the 1-year modified Rankin Scale score distribution versus medical care alone (Wilcoxon-Mann-Whitney probability of superiority 0·59 [95% CI 0·53-0·64]; p=0·0019; generalised odds ratio 1·43 [95% CI 1·14-1·78]). At the 1-year follow-up, 77 (45%) of 170 patients receiving thrombectomy had died, compared with 83 (52%) of 159 patients receiving medical care only (1-year mortality relative risk 0·89 [95% CI 0·71-1·11]).
INTERPRETATION: In patients with ischaemic stroke due to a proximal occlusion and large core, thrombectomy plus medical care provided a significant functional outcome benefit compared with medical care alone at 1-year follow-up.
FUNDING: Stryker Neurovascular.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:403 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 403(2024), 10428 vom: 24. Feb., Seite 731-740 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Clinical Trial, Phase III |
|---|
| Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print-Electronic ClinicalTrials.gov: NCT03876457 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(24)00050-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368365794 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368365794 | ||
| 003 | DE-627 | ||
| 005 | 20240229155245.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240213s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(24)00050-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1306.xml |
| 035 | |a (DE-627)NLM368365794 | ||
| 035 | |a (NLM)38346442 | ||
| 035 | |a (PII)S0140-6736(24)00050-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sarraj, Amrou |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke |b 1-year outcomes of the SELECT2 trial |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.02.2024 | ||
| 500 | |a Date Revised 26.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT03876457 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND: Multiple randomised trials have shown efficacy and safety of endovascular thrombectomy in patients with large ischaemic stroke. The aim of this study was to evaluate long-term (ie, at 1 year) evidence of benefit of thrombectomy for these patients | ||
| 520 | |a METHODS: SELECT2 was a phase 3, open-label, international, randomised controlled trial with blinded endpoint assessment, conducted at 31 hospitals in the USA, Canada, Spain, Switzerland, Australia, and New Zealand. Patients aged 18-85 years with ischaemic stroke due to proximal occlusion of the internal carotid artery or of the first segment of the middle cerebral artery, showing large ischaemic core on non-contrast CT (Alberta Stroke Program Early Computed Tomographic Score of 3-5 [range 0-10, with lower values indicating larger infarctions]) or measuring 50 mL or more on CT perfusion and MRI, were randomly assigned, within 24 h of ischaemic stroke onset, to thrombectomy plus medical care or to medical care alone. The primary outcome for this analysis was the ordinal modified Rankin Scale (range 0-6, with higher scores indicating greater disability) at 1-year follow-up in an intention-to-treat population. The trial is registered at ClinicalTrials.gov (NCT03876457) and is completed | ||
| 520 | |a FINDINGS: The trial was terminated early for efficacy at the 90-day follow-up after 352 patients had been randomly assigned (178 to thrombectomy and 174 to medical care only) between Oct 11, 2019, and Sept 9, 2022. Thrombectomy significantly improved the 1-year modified Rankin Scale score distribution versus medical care alone (Wilcoxon-Mann-Whitney probability of superiority 0·59 [95% CI 0·53-0·64]; p=0·0019; generalised odds ratio 1·43 [95% CI 1·14-1·78]). At the 1-year follow-up, 77 (45%) of 170 patients receiving thrombectomy had died, compared with 83 (52%) of 159 patients receiving medical care only (1-year mortality relative risk 0·89 [95% CI 0·71-1·11]) | ||
| 520 | |a INTERPRETATION: In patients with ischaemic stroke due to a proximal occlusion and large core, thrombectomy plus medical care provided a significant functional outcome benefit compared with medical care alone at 1-year follow-up | ||
| 520 | |a FUNDING: Stryker Neurovascular | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Clinical Trial, Phase III | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 700 | 1 | |a Abraham, Michael G |e verfasserin |4 aut | |
| 700 | 1 | |a Hassan, Ameer E |e verfasserin |4 aut | |
| 700 | 1 | |a Blackburn, Spiros |e verfasserin |4 aut | |
| 700 | 1 | |a Kasner, Scott E |e verfasserin |4 aut | |
| 700 | 1 | |a Ortega-Gutierrez, Santiago |e verfasserin |4 aut | |
| 700 | 1 | |a Hussain, Muhammad Shazam |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Johns, Hannah |e verfasserin |4 aut | |
| 700 | 1 | |a Churilov, Leonid |e verfasserin |4 aut | |
| 700 | 1 | |a Pujara, Deep K |e verfasserin |4 aut | |
| 700 | 1 | |a Shaker, Faris |e verfasserin |4 aut | |
| 700 | 1 | |a Maali, Laith |e verfasserin |4 aut | |
| 700 | 1 | |a Cardona Portela, Pere |e verfasserin |4 aut | |
| 700 | 1 | |a Herial, Nabeel A |e verfasserin |4 aut | |
| 700 | 1 | |a Gibson, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Kozak, Osman |e verfasserin |4 aut | |
| 700 | 1 | |a Arenillas, Juan F |e verfasserin |4 aut | |
| 700 | 1 | |a Yan, Bernard |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez de la Ossa, Natalia |e verfasserin |4 aut | |
| 700 | 1 | |a Sundararajan, Sophia |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Yin C |e verfasserin |4 aut | |
| 700 | 1 | |a Cordato, Dennis J |e verfasserin |4 aut | |
| 700 | 1 | |a Manning, Nathan W |e verfasserin |4 aut | |
| 700 | 1 | |a Hanel, Ricardo A |e verfasserin |4 aut | |
| 700 | 1 | |a Aghaebrahim, Amin N |e verfasserin |4 aut | |
| 700 | 1 | |a Budzik, Ronald F |e verfasserin |4 aut | |
| 700 | 1 | |a Hicks, William J |e verfasserin |4 aut | |
| 700 | 1 | |a Blasco, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Teddy Y |e verfasserin |4 aut | |
| 700 | 1 | |a Tsai, Jenny P |e verfasserin |4 aut | |
| 700 | 1 | |a Schaafsma, Joanna D |e verfasserin |4 aut | |
| 700 | 1 | |a Gandhi, Chirag D |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Mufti, Fawaz |e verfasserin |4 aut | |
| 700 | 1 | |a Sangha, Navdeep |e verfasserin |4 aut | |
| 700 | 1 | |a Warach, Steven |e verfasserin |4 aut | |
| 700 | 1 | |a Kleinig, Timothy J |e verfasserin |4 aut | |
| 700 | 1 | |a Yogendrakumar, Vignan |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Felix |e verfasserin |4 aut | |
| 700 | 1 | |a Samaniego, Edgar A |e verfasserin |4 aut | |
| 700 | 1 | |a Abdulrazzak, Mohammad A |e verfasserin |4 aut | |
| 700 | 1 | |a Parsons, Mark W |e verfasserin |4 aut | |
| 700 | 1 | |a Rahbar, Mohammad H |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Thanh N |e verfasserin |4 aut | |
| 700 | 1 | |a Fifi, Johanna T |e verfasserin |4 aut | |
| 700 | 1 | |a Mendes Pereira, Vitor |e verfasserin |4 aut | |
| 700 | 1 | |a Lansberg, Maarten G |e verfasserin |4 aut | |
| 700 | 1 | |a Albers, Greg W |e verfasserin |4 aut | |
| 700 | 1 | |a Furlan, Anthony J |e verfasserin |4 aut | |
| 700 | 1 | |a Jabbour, Pascal |e verfasserin |4 aut | |
| 700 | 1 | |a Sitton, Clark W |e verfasserin |4 aut | |
| 700 | 1 | |a Sila, Cathy |e verfasserin |4 aut | |
| 700 | 1 | |a Bambakidis, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Stephen M |e verfasserin |4 aut | |
| 700 | 1 | |a Wechsler, Lawrence |e verfasserin |4 aut | |
| 700 | 1 | |a Hill, Michael D |e verfasserin |4 aut | |
| 700 | 1 | |a Grotta, James C |e verfasserin |4 aut | |
| 700 | 1 | |a Ribo, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Bruce C V |e verfasserin |4 aut | |
| 700 | 0 | |a SELECT2 Investigators |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 403(2024), 10428 vom: 24. Feb., Seite 731-740 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:403 |g year:2024 |g number:10428 |g day:24 |g month:02 |g pages:731-740 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(24)00050-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 403 |j 2024 |e 10428 |b 24 |c 02 |h 731-740 | ||